BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 22882694)

  • 1. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.
    Brandão A; Fuchs SC; Gleisner AL; Marroni C; Zanotelli ML; Cantisani G
    Clin Transplant; 2008; 22(5):651-6. PubMed ID: 18549449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A; Angermayr B; Bertolini G; Koenig F; Vizzini G; Ploner M; Peck-Radosavljevic M; Gridelli B; Bosch J
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW; Rodriguez HJ; Bacchetti P; Bass NM; Roberts JP; Terrault NA
    Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].
    Zhang JY; Qin CY; Jia JD; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):108-11. PubMed ID: 22464781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose.
    Craig DG; Reid TW; Wright EC; Martin KG; Davidson JS; Hayes PC; Simpson KJ
    Aliment Pharmacol Ther; 2012 Mar; 35(6):705-13. PubMed ID: 22260637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease-sodium and survival benefit in liver transplantation.
    Vitale A; Bertacco A; Gambato M; D'Amico F; Morales RR; Frigo AC; Zanus G; Burra P; Angeli P; Cillo U
    Transpl Int; 2013 Feb; 26(2):138-44. PubMed ID: 23194386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis.
    Jiang M; Liu F; Xiong WJ; Zhong L; Chen XM
    World J Gastroenterol; 2008 Nov; 14(42):6546-50. PubMed ID: 19030210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.